This treatment applies to Dogs.
Canine Parvovirus Vaccine
Modified Live Virus
For use in dogs only.
NeoPar® is a modified live virus vaccine containing a high antigenic mass per dose of a highly immunogenic strain of canine parvovirus.
Gentamicin and Amphotericin B are used as preservatives.
NeoPar® is for the vaccination of healthy dogs against disease due to canine parvovirus. NeoPar® is designed to be used primarily where the severe threat of canine parvovirus infections exists in the resident dog population.
This vaccine gives reliable protection against infections by other known strains of canine parvovirus.
NeoPar® overrides moderate to high antibody levels such as those found in puppies having maternal antibodies or in dogs from pre-existing vaccination. It can be used successfully as a booster for a pre-existing vaccination.
Puppies vaccinated with NeoPar® generated high levels of the IgM and IgG classes of antibodies. Secretory immunity was engendered in the gut. Reversion to virulence does not occur. Field studies indicate that this vaccine is safe in puppies at or about 42 days of age or older.
This item is NON-RETURNABLE and NON-REFUNDABLE.